Filing Details

Accession Number:
0000950170-24-116048
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-21 20:22:37
Reporting Period:
2021-05-03
Accepted Time:
2024-10-21 20:22:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1341235 Aldeyra Therapeutics Inc. ALDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1735084 Nancy Miller-Rich C/O Aldeyra Therapeutics, Inc.
131 Hartwell Avenue
Lexington MA 02421
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-03 413 $12.81 413 No 4 P Direct
Common Stock Acquisiton 2023-04-12 509 $10.13 922 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchases reported herein were executed under the trading discretion of an investment advisor in a managed account, without any instruction from or knowledge of the Reporting Person. The Reporting Person only recently become aware of these transactions.